NEU ASX Chart
Snapshot
Neuren Pharmaceuticals Limited (NEU) is a biopharmaceutical company developing new drug therapies to treat multiple serious neurological disorders that emerge in early childhood and have no or limited approved treatment options. Recognising the urgent unmet need, all programs have been granted "orphan drug" designation in the United States. Orphan drug designation provides incentives to encourage development of therapies for rare and serious diseases.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2024 YTD | |
1 Year | |
vs Sector (1yr) | -31.23% |
vs ASX 200 (1yr) | -34.73% |
Announcements
Corporate Overview
Corporate Details
Head Office | Auckland New Zealand 1141 |
Website | www.neurenpharma.com |
Registry | Link Market Services |
Auditor | Grant Thornton New Zealand Audit Limited |
Date Listed | 3 Feb 2005 |
Upcoming Calendar (Forecasted)
Date | Event |
---|---|
27/02/2025 | Report (Prelim) |
22/04/2025 | Report (Annual) |
26/08/2025 | Report (Interim) |
Former Company Names
- Neuren Pharmaceuticals Ltd has no former company names.
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
NEU directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of NEU directors.
Shareholder Info
Substantial Shareholders
No Substantial Shareholders for NEU in our database.
Shareholders Buying
12 month transaction history compiled from ASX announcements.
No buy transactions reported by Substantial Shareholders in the past 12 months.
Shareholders Selling
12 month transaction history compiled from ASX announcements.
Date | Name | Sold | Previous % | New % |
---|---|---|---|---|
17-07-24 | Milford Asset Management Limited | 6,561,977 | 5.09 | -- |
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2024 | $21.27 | 28 June |
2023 | $12.25 | 30 June |
2022 | $3.80 | 30 June |
2021 | $1.63 | 30 June |
2020 | $1.37 | 30 June |
2019 | $1.15 | 28 June |
2018 | $2.97 | 29 June |
2017 | $0.068 | 30 June |
2016 | $0.055 | 30 June |
2015 | $0.079 | 30 June |
2014 | $0.083 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.